Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Return on Equity [ROE] (2010 - 2026)

Updated

Vistagen Therapeutics (VTGN) recorded Return on Equity [ROE] of -298.78% in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 197.65 percentage points from -101.12% a year earlier and down 73.35 percentage points from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Return on Equity [ROE] (2010 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Vistagen Therapeutics reported Return on Equity [ROE] of -131.61%, down 75.93 percentage points from FY2025.

  • Annual Return on Equity [ROE] has a five-year change of -90.02 percentage points (FY2021 to FY2026).
  • Across earlier fiscal years, Return on Equity [ROE] came in at -55.68% in FY2025 (-9.21 pp), -46.47% in FY2024 (+107.83 pp), -154.30% in FY2023 (-93.34 pp) and -60.96% in FY2022 (-19.38 pp).
  • The fiscal Q2 2027 figure is the lowest quarterly Return on Equity [ROE] since fiscal Q1 2024.
  • On a year-over-year basis, Return on Equity [ROE] has declined for eight consecutive quarters, with an average year-over-year change of -83.06 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 459.68 percentage points in fiscal Q1 2025, against a drop of 382.02 percentage points in fiscal Q1 2024 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at -225.42% (Q1 2027), -161.25% (Q4 2026) and -114.35% (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -1,456.09%
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 74.39%
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 19.33%
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn -
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 5.63%
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 72.13%
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn -31.17%
9 Gsk 193.54 Bn 176.38 Bn - -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - -298.78%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -298.78%
Jun 30, 2026 -225.42%
Mar 31, 2026 -161.25%
Dec 31, 2025 -114.35%
Sep 30, 2025 -101.12%
Jun 30, 2025 -87.74%
Mar 31, 2025 -67.87%
Dec 31, 2024 -54.33%
Sep 30, 2024 -39.99%
Jun 30, 2024 -30.30%
Mar 31, 2024 -24.72%
Dec 31, 2023 -40.35%
Sep 30, 2023 -166.98%
Jun 30, 2023 -489.98%
Mar 31, 2023 -361.77%
Dec 31, 2022 -253.42%
Sep 30, 2022 -170.46%
Jun 30, 2022 -107.96%
Mar 31, 2022 -66.02%
Dec 31, 2021 -46.42%
API Access

Vistagen Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VTGN&period=max&api_key=YOUR_API_KEY